These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 816716)

  • 1. [Subcutaneous calcium heparin in hemodialysis (author's transl)].
    Molinari ML; Zoni G
    Haematologica; 1975 Dec; 60(4):466-76. PubMed ID: 816716
    [No Abstract]   [Full Text] [Related]  

  • 2. [Heparin dosage in chronic hemodialysis (author's transl)].
    Vogel GE; Hansen W; Goldmann FL; Kopp KF
    Med Klin; 1977 Oct; 72(40):1617-23. PubMed ID: 916946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lipaemic profile of patients subjected to long-term haemodialysis and acute changes associated with haemodialysis and the use of heparin (author's transl)].
    Koslík S; Takác M
    Sb Lek; 1981 Jul; 83(6-7):162-8. PubMed ID: 7268304
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on the measurement of blood ionized calcium in patients undergoing chronic hemodialysis (author's transl)].
    Imada A; Horiuchi A; Kogi Y; Kawauchi Y
    Rinsho Byori; 1981 Nov; 29(11):1136-40. PubMed ID: 7334668
    [No Abstract]   [Full Text] [Related]  

  • 5. [Kinetics of anticoagulation in hemodialysis. Sequential study of single, intermittent and continuous heparinization].
    Ghezzi PM; Di Siena F; Palanca R; Dutto A; Cento G
    Minerva Med; 1980 Oct; 71(41):2987-91. PubMed ID: 7454084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Heparin-free hemodialysis in chronic patients for temporary management of conditions with a high risk of bleeding].
    Stradtmann H; Förster S; Jalinski W
    Z Urol Nephrol; 1988 Jul; 81(7):449-53. PubMed ID: 3176720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [On the problem of calcium concentration in water and in the dialysate in Czech hemodialysis centres (author's transl)].
    Vokrouhlická O; Blahosová A; Pantũcek M; Plocková E; Erben J
    Cas Lek Cesk; 1976 Dec; 115(52):1611-3. PubMed ID: 1017008
    [No Abstract]   [Full Text] [Related]  

  • 8. Heparin-induced thrombocytopenia in renal failure.
    Hall AV; Clark WF; Parbtani A
    Clin Nephrol; 1992 Aug; 38(2):86-9. PubMed ID: 1516285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemodialysis without risk of hemorrhage. Introduction of an APTT bedside method for exact heparin monitoring--a review].
    Vogel GE
    Fortschr Med; 1977 Oct; 95(40):2437-44. PubMed ID: 924326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of regional heparinization during hemodialysis].
    Koslík S; Mydlík M; Melnicák P; Kochan I; Gayová E
    Vnitr Lek; 1976 Oct; 22(10):981-6. PubMed ID: 982866
    [No Abstract]   [Full Text] [Related]  

  • 11. [Changes in blood coagulation mechanism in patients with chronic renal failure kept on chronic or iterative hemodialysis (author's transl)].
    Grgicević D; Antos M; Pistotnik M; Prejac M; Flego I
    Lijec Vjesn; 1977 May; 99(5):307-10. PubMed ID: 886907
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hemodialysis of patients in terminal renal insufficiency].
    Enger E; Halvorsen S
    Tidsskr Nor Laegeforen; 1971 May; 91(15):1139-54. PubMed ID: 4934913
    [No Abstract]   [Full Text] [Related]  

  • 13. The safety of heparins in end-stage renal disease.
    Sonawane S; Kasbekar N; Berns JS
    Semin Dial; 2006; 19(4):305-10. PubMed ID: 16893408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical analysis of 6,348 instances of blood dialysis (author's transl)].
    Liao LT
    Zhonghua Nei Ke Za Zhi; 1981 Jun; 20(6):326-30. PubMed ID: 7318584
    [No Abstract]   [Full Text] [Related]  

  • 15. Fluoridated water, hemodialysis, and renal disease.
    Med Lett Drugs Ther; 1969 Aug; 11(16):67-8. PubMed ID: 5820566
    [No Abstract]   [Full Text] [Related]  

  • 16. Regional citrate anticoagulation in chronic hemodialysis patients.
    Seaton RD; Duncan KA; Pinnick RV; Diederich DA; Wiegmann TB
    Trans Am Soc Artif Intern Organs; 1983; 29():414-8. PubMed ID: 6673262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Citrate anticoagulation and dialysate with reduced buffer content in chronic hemodialysis.
    van der Meulen J; Janssen MJ; Langendijk PN; Bouman AA; Oe PL
    Clin Nephrol; 1992 Jan; 37(1):36-41. PubMed ID: 1541063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Rehabilitation of patients on chronic hemodialysis (author's transl)].
    Krpan A; Molnar V; Varlaj V
    Lijec Vjesn; 1976 May; 98(5):267-9. PubMed ID: 979512
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety and efficacy of epoprostenol (PGI2) versus heparin (H) in hemodialysis (HD).
    Dubrow A; Flamenbaum W; Mittman N; Hall J; Zinn J
    Trans Am Soc Artif Intern Organs; 1984; 30():52-4. PubMed ID: 6398552
    [No Abstract]   [Full Text] [Related]  

  • 20. [Present status of dialysis therapy in Hokkaido (author's transl)].
    Ogawa H
    Hokkaido Igaku Zasshi; 1980 Nov; 55(6):489-93. PubMed ID: 7024076
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.